Suit Over 'Illegal' CBD Products Paused To Await FDA Rules
By Jack Queen (May 26, 2020, 5:16 PM EDT) -- A California federal court has paused a proposed class action accusing a CBD company of hawking products that aren't compliant with U.S. Food and Drug Administration guidelines, saying the case should wait until the agency unveils new cannabinoid regulations.
U.S. District Judge Virginia A. Phillips on Friday became the second judge to call timeout in a wave of lawsuits prompted by FDA warnings that cannabinoid products are being sold illegally, finding the case against CBD maker CV Sciences Inc. would benefit from regulatory clarity.
"The fact remains that the FDA has not formally established its position," Judge Phillips said, noting that...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!